Showing results (91-100 of 553) with videos related to

Sort By:
Pageof 56
Drugs in Context|February 28, 2025
Obinutuzumab in membranous nephropathy: a potential game-changer in treatmentConcetto Sessa, Dario Galeano, Luca Zanoli, et al.
Drugs in Context|December 3, 2024
Patient journey in cystinosis: focus on non-adherence and disease managementGema Ariceta, Simón Lalanza, Catalina Peña, et al.
Drugs in Context|December 3, 2024
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazineMarta Matrone, Alessandro Cuomo, Sergio De Filippis, et al.
Drugs in Context|March 13, 2025
Lecanemab for mild Alzheimer disease - is there a way forward?Rajesh R Tampi
Drugs in Context|July 29, 2024
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case seriesCarlo Lombardi, Francesco Menzella, Alvise Berti
Drugs in Context|July 11, 2024
Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case reportArun Madhab Boruah, Dibyendu Banerjee, Farendra Bhardwaj, et al.
Drugs in Context|August 27, 2024
RNA interference therapy in cardiology: will new targets improve therapeutic goals?Renata Tj Fazoli, Luciano F Drager, Roberto Kalil-Filho, et al.
Drugs in Context|June 20, 2024
The use of Arista AH as a local haemostatic agent in distal splenopancreatectomy: report of two casesMattia Di Benedetto, Marco Gramellini, Stefano Bona, et al.
Drugs in Context|May 3, 2024
Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settingsIrsan Hasan, Ignatia Sinta Murti, Putut Bayupurnama, et al.
Drugs in Context|May 31, 2024
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature reviewSara Munari, Giulia Ciotti, Walter Cestaro, et al.
Pageof 56